Cargando…
AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
Background: Autologous stem cell transplantation (ASCT) remains an effective treatment option for many patients with systemic light chain (AL) amyloidosis. While maintenance post ASCT in multiple myeloma is now standard, the decision to utilize maintenance in AL amyloidosis remains largely unexplore...
Autores principales: | Ozga, Michael, Zhao, Qiuhong, Benson, Don, Elder, Patrick, Williams, Nita, Bumma, Naresh, Rosko, Ashley, Chaudhry, Maria, Khan, Abdullah, Devarakonda, Srinivas, Kahwash, Rami, Vallakati, Ajay, Campbell, Courtney, Parikh, Samir V., Almaani, Salem, Prosek, Jason, Bittengle, Jordan, Pfund, Katherine, LoRusso, Samantha, Freimer, Miriam, Redder, Elyse, Efebera, Yvonne, Sharma, Nidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700492/ https://www.ncbi.nlm.nih.gov/pubmed/33238501 http://dx.doi.org/10.3390/jcm9113778 |
Ejemplares similares
-
AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival
por: Ozga, Michael, et al.
Publicado: (2020) -
Multidisciplinary amyloidosis care in the era of personalized medicine
por: Bumma, Naresh, et al.
Publicado: (2022) -
Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022) -
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020
por: Devarakonda, Srinivas, et al.
Publicado: (2020) -
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience
por: Nunnelee, Jordan, et al.
Publicado: (2022)